Solstice Raises $21M Investment to Accelerate Pharma Marketing Cycle Revolution

Solstice, an AI-native marketing agency, secures $21M in Series A funding to revolutionize the process of transforming clinical evidence into compliant marketing campaigns, reducing the review cycle to less than 48 hours.